Welcome
Support Centre
07 August 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A Randomised Controlled Trial of Treatment of Unilateral Straight Eyed Visual Acuity Deficit
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN06512650
Date ISRCTN assigned23/01/2004
Local reference number(s)RRCC7R R1903/6624
Public titleA Randomised Controlled Trial of Treatment of Unilateral Straight Eyed Visual Acuity Deficit
Scientific title
AcronymN/A
Disease/condition/study domainEye diseases: Eye diseases
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaChildren aged 3-4 years, with lateral visual acuity defects of 6/9 to 6/24.
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date28/02/1999
Anticipated end date28/02/2002
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsThe effects of correction of refractive error, alone and in combination with patching will be compared to no treatment.
Primary outcome measure(s)The main outcome measure at both the preliminary and final analysis will be LogMAR acuity. Anova will be used to test the effect of group and sub-group analyses will test for heterogeneity between and at different initial acuities.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingNHS Executive Northern and Yorkshire
Sponsor nameNHS R&D Regional Programme Register - Department of Health (UK)
Sponsor detailsThe Department of Health
Richmond House
79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44 (0)20 7307 2623
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.doh.gov.uk
Contact nameDr Michael Clarke
Contact detailsRoyal Victoria Infirmary
Eye Department
Queen Victoria Road
Newcastle upon Tyne
United Kingdom
NE1 4LP
Contact telephone+44 (0)191 232 5131
Contact fax+44 (0)191 201 0155
Contact emailm.p.clarke@ncl.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN06512650
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central